THYROID GLAND PAPILLARY CARCINOMA
Clinical trials for THYROID GLAND PAPILLARY CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new THYROID GLAND PAPILLARY CARCINOMA trials appear
Sign up with your email to follow new studies for THYROID GLAND PAPILLARY CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug shrinks thyroid tumors before surgery in early trial
Disease control OngoingThis study tests whether giving the drug selpercatinib before surgery can shrink thyroid cancers that have a specific genetic change (RET alteration). About 30 people with advanced or recurrent thyroid cancer will receive the drug and then have surgery. The goal is to see if the …
Matched conditions: THYROID GLAND PAPILLARY CARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 04:16 UTC
-
New drug cocktail shows promise for Hard-to-Treat thyroid cancer
Disease control OngoingThis study tests a combination of three drugs (cabozantinib, nivolumab, and ipilimumab) in people with a type of thyroid cancer that no longer responds to radioactive iodine and has worsened after one prior targeted therapy. The goal is to see if this mix can shrink tumors or slo…
Matched conditions: THYROID GLAND PAPILLARY CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 20, 2026 11:55 UTC